Gerald P. McDole
Director/Board Member at PALADIN LABS INC.
Net worth: 36 223 $ as of 29/04/2024
Gerald P. McDole active positions
| Companies | Position | Start | End |
|---|---|---|---|
| PALADIN LABS INC. | Director/Board Member | 31/12/2003 | - |
| Independent Dir/Board Member | 19/10/2011 | - | |
| Canadian Healthcare Marketing Hall of Fame | Corporate Officer/Principal | 14/09/2010 | - |
| Innovation Institute of Ontario | Director/Board Member | - | - |
| Canadian Genetic Disease Network | Director/Board Member | - | - |
Career history of Gerald P. McDole
Former positions of Gerald P. McDole
| Companies | Position | Start | End |
|---|---|---|---|
| MEDICURE INC. | Director/Board Member | 15/01/2004 | 30/01/2023 |
| Independent Dir/Board Member | 15/01/2004 | 30/01/2023 | |
| CIPHER PHARMACEUTICALS INC. | Director/Board Member | 22/02/2004 | 05/02/2014 |
| Chairman | 05/02/2014 | 08/08/2016 | |
| Independent Dir/Board Member | 22/02/2004 | 08/08/2016 | |
NeuroMedix, Inc.
 NeuroMedix, Inc. Pharmaceuticals: MajorHealth Technology NeuroMedix, Inc. develops pharmaceutical products. The company makes therapeutic agents for the treatment of degenerative and inflammatory diseases of the central nervous system, such as Alzheimer's disease and multiple sclerosis. It also develops therapies for the treatment of other degenerative neuroinflammatory diseases, such as Parkinson's. NeuroMedix was founded in 2005 and is headquartered in Toronto, Canada. | Director/Board Member | - | 19/03/2007 |
| Astra Pharmaceuticals, Inc. | Chief Executive Officer | 31/12/1984 | 30/09/2003 |
| President | 31/12/1984 | 30/09/2003 | |
AstraZeneca Canada, Inc.
 AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology AstraZeneca Canada, Inc. develops and manufactures pharmaceutical drug preparations. Its therapeutic areas include cardiovascular and metabolic disease, oncology, and respiratory, inflammation and autoimmunity. The firm also active in the infection, neuroscience and gastrointestinal disease areas. The company was founded in 1999 and is headquartered in Mississauga, Canada. | Chief Executive Officer | 31/12/1998 | 31/12/2002 |
| President | 31/12/1998 | 31/12/2002 | |
| ░░░░░ ░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - | |
| ░░░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░░░░ ░░░░░░░░░░ ░░░ ░░░░░░░░ | ░░░░░░░░░ | - | - |
| ░░░░░░░░ ░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░░░ ░░ ░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░ | - | - |
| ░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | - | - |
Training of Gerald P. McDole
| Simon Fraser University | Masters Business Admin |
| University of Manitoba | Undergraduate Degree |
Statistics
International
| Canada | 17 |
| United States | 2 |
Operational
| Director/Board Member | 8 |
| President | 4 |
| Independent Dir/Board Member | 3 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 3 |
| Commercial Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| MEDICURE INC. | Health Technology |
| CIPHER PHARMACEUTICALS INC. | Health Technology |
| Private companies | 13 |
|---|---|
Paladin Labs, Inc.
 Paladin Labs, Inc. Pharmaceuticals: MajorHealth Technology Paladin Labs Inc. operates as pharmaceutical company. It engages in developing, acquiring, in-licensing, marketing, and distributing innovative pharmaceutical products in Canada and internationally. The firm's products include Abstral, GlucaGen, Metadol, Plan B, Pennsaid, Seasonale, Testim, Twinject, Dexedrin, Tridural, and Trelstar. The company was founded by Jonathan Ross Goodman and Mark Beaudet on February 25, 1983 and is headquartered in Montreal, Canada. | Health Technology |
NeuroMedix, Inc.
NeuroMedix, Inc. Pharmaceuticals: MajorHealth Technology NeuroMedix, Inc. develops pharmaceutical products. The company makes therapeutic agents for the treatment of degenerative and inflammatory diseases of the central nervous system, such as Alzheimer's disease and multiple sclerosis. It also develops therapies for the treatment of other degenerative neuroinflammatory diseases, such as Parkinson's. NeuroMedix was founded in 2005 and is headquartered in Toronto, Canada. | Health Technology |
AstraZeneca Canada, Inc.
AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology AstraZeneca Canada, Inc. develops and manufactures pharmaceutical drug preparations. Its therapeutic areas include cardiovascular and metabolic disease, oncology, and respiratory, inflammation and autoimmunity. The firm also active in the infection, neuroscience and gastrointestinal disease areas. The company was founded in 1999 and is headquartered in Mississauga, Canada. | Health Technology |
| Canadian Genetic Disease Network | |
| Innovation Institute of Ontario | |
| Astra Pharmaceuticals, Inc. | |
| Institute of Health Economics | |
Sti Technologies Ltd.
 Sti Technologies Ltd. Miscellaneous Commercial ServicesCommercial Services STI Technologies Ltd. provides marketing solutions to the health care industry. The firm's SmartTechnology platform allows stakeholders-manufacturers, pharmacies, prescribers, and payers to optimize their patient relationships. It offers solutions for pre-launch planning, brand adoption, market uptake, revenue optimization, retention and adherence, and loss of exclusivity. The company was founded by William B. Adams and Gregory Patey in 2001 and is headquartered in Halifax, Canada. | Commercial Services |
| Advanced Coronary Treatment Foundation | |
Canadian Stroke Network
 Canadian Stroke Network Miscellaneous Commercial ServicesCommercial Services Canadian Stroke Network operates as a non-profit healthcare organization. The company was founded in 1999 and is headquartered in Ottawa, Canada. | Commercial Services |
| Canadian Foundation for Pharmacy | |
| Canadian Healthcare Marketing Hall of Fame | |
| Astra Pharma, Inc. |
- Stock Market
- Insiders
- Gerald P. McDole
- Experience
